LONGEVERON INC.

Insiders Longeveron Inc.

Equities

LGVN

US54303L2034

Market Closed - Nasdaq Other stock markets 21:00:00 07/05/2024 BST			5-day change	1st Jan Change
1.68 ^USD	0.00%		-1.75%	-87.65%

04-30	Longeveron Files Prospectus for Secondary Offering	MT
04-15	Top Premarket Gainers	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Longeveron Names Lisa Locklear as CFO	20/07/23	MT
Longeveron Inc. Announces the Appointment of Lisa Locklear as Chief Financial Officer, Effective July 31, 2023	20/07/23	CI
Longeveron Inc. Announces Appointment of Lisa Locklear as Executive Vice President, Effective July 31, 2023	20/07/23	CI
Longeveron Inc. Appoints Nataliya Agafonova M.D. as Chief Medical Officer	05/07/23	CI
Longeveron Inc. Approves Bord Appointments	12/06/23	CI
Longeveron Inc. Announces Resignation of James Clavijo as CFO	05/06/23	CI
Longeveron Inc. Announces Resignation of James Clavijo as Chief Financial Officer, Effective June 9, 2023	10/04/23	CI
Longeveron Appoints Wa'el Hashad as Chief Executive Officer, Effective March 1, 2023	28/02/23	CI
Insider Sell: Longeveron	18/10/22	MT
Longeveron Inc. Announces Executive Changes	09/05/22	CI
Insider Sell: Longeveron	20/04/22	MT
Longeveron Appoints Chris Min as Chief Medical Officer	06/04/22	MT
Longeveron Inc. Appoints K. Chris Min as Chief Medical Officer	05/04/22	CI
Longeveron Inc. Appoints Todd C. Girolamo to Its Audit Committee	17/02/22	CI
Longeveron Inc. Appoints Todd Girolamo to Its Board of Directors	17/02/22	CI
Longeveron Announces the Appointment of Ursula Ungaro to its Board of Directors, Effective June 1, 2021	25/05/21	CI
Longeveron Inc. Announces the Hiring of Dan Gincel as Senior Vice President, Strategic Collaborations & Scientific Affairs	18/05/21	CI
Longeveron Inc. Announces Board Appointments	18/02/21	CI
Longeveron LLC Appoints Arin Maercks as Chief Commercial Officer	29/08/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer